Jaina, Adryll R.

HRN: 23-83-88  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
CEFTAZIDIME 1GM (VIAL)
10/18/2023
10/25/2023
IV
70mg
BID
Neonatal Sepsis; Omphalitis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: